Skip to main content
BEAT
NASDAQ Industrial Applications And Services

HeartBeam Seeks Shareholder Approval for 6% Equity Plan Dilution to Fund Compensation Amidst Going Concern

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.75
Mkt Cap
$42.163M
52W Low
$0.54
52W High
$4
52W Position info
39% above low
Off High info
81% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BEAT sits 39% above its 52-week low of $0.54.

Summary

HeartBeam, Inc. filed its definitive proxy statement for its annual meeting, seeking shareholder approval to increase its equity incentive plan by 3 million shares, representing a potential 6% dilution, to support compensation and conserve cash.


Key Events · Corporate Governance and Compliance · BEAT

  • Annual Shareholder Meeting Scheduled

    The company will hold its 2026 Annual Meeting of Shareholders virtually on July 31, 2026.

  • Proposed Equity Plan Expansion

    Shareholders will vote on amending the 2022 Equity Incentive Plan to increase authorized shares by 3,000,000, which would result in a potential additional dilution of 6%.

  • Equity Compensation Strategy

    The proposed increase supports the company's strategy of using equity grants in lieu of cash for executive and director compensation, a critical measure for cash conservation given the reiterated 'going concern' warning.

  • Compliance Issues Noted

    The filing discloses that several directors and officers had late Form 4 filings in 2025 related to stock dispositions and equity grants.


Analysis · BEAT · Industrial Applications And Services

HeartBeam, Inc. is asking shareholders to approve an amendment to its 2022 Equity Incentive Plan to increase authorized shares by 3,000,000. This represents a potential additional dilution of 6% to existing shareholders. While dilutive, this move is critical for the company to continue using equity compensation for executives and directors, a strategy already employed in 2025 to conserve cash. This is particularly important given the company's reiterated 'going concern' warning, as it provides a mechanism to retain talent without further straining liquidity. The filing also notes several late Form 4 filings by directors and officers in 2025, indicating compliance oversight issues.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BEAT was trading at $0.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $42.2M. The 52-week trading range was $0.54 to $4.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BEAT - Latest Insights

BEAT
Nov 12, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3969
Real-time Price: $0.294 info
Change: -$0.1029 (-26%) info
Market Cap: $18.107M info
BEAT
Nov 12, 2026, 4:01 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.4053
Real-time Price: $0.294 info
Change: -$0.1113 (-27%) info
Market Cap: $18.107M info
BEAT
Nov 02, 2026, 8:31 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.5402
Real-time Price: $0.294 info
Change: -$0.2462 (-46%) info
Market Cap: $18.107M info
BEAT
Oct 26, 2026, 8:38 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.4061
Real-time Price: $0.294 info
Change: -$0.1121 (-28%) info
Market Cap: $18.107M info
BEAT
Oct 05, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $0.697014
Real-time Price: $0.294 info
Change: -$0.403014 (-58%) info
Market Cap: $18.107M info